P T McNamee
Overview
Explore the profile of P T McNamee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
Hasselwander O, Savage D, McMaster D, Loughrey C, McNamee P, Middleton D, et al.
Kidney Int
. 1999 Jul;
56(1):289-98.
PMID: 10411705
Background: Paraoxonase (PON1) gene variants have been identified as risk factors for cardiovascular disease (CVD). There are two common PON1 polymorphisms at position 55 (Leu-Met change) and 192 (Gln-Arg change)...
12.
McCullagh J, McNamee P, Smyth J, Ball H
Vet Microbiol
. 1998 Dec;
63(2-4):275-81.
PMID: 9851005
Pulsed field gel electrophoresis (PFGE) analysis of SmaI restriction patterns was used to type 109 isolates of Staphylococcus aureus collected from broiler farms and hatcheries in Northern Ireland. Forty-seven isolates...
13.
McNamee P, McCullagh J, Thorp B, Ball H, Graham D, McCullough S, et al.
Vet Rec
. 1998 Sep;
143(5):131-5.
PMID: 9725184
The major causes of leg weakness/lameness were investigated in two male commercial broiler flocks. The numbers of dead and lame birds culled from the flocks each day were recorded by...
14.
Brown J, Douglas A, Murphy B, Hill C, McNamee P, Nelson W, et al.
Nephrol Dial Transplant
. 1998 Mar;
13(2):443-8.
PMID: 9509460
Background: Progressive deterioration in renal function occurs in 20-50% of patients with idiopathic membranous nephropathy (IMN). Several treatment regimens have been used to reverse this with varying effect and toxicity....
15.
McEneny J, Loughrey C, McNamee P, Trimble E, Young I
Atherosclerosis
. 1997 Mar;
129(2):215-20.
PMID: 9105564
Oxidation of VLDL in vitro increases macrophage uptake and promotes foam cell formation, and the dyslipidaemia of chronic renal failure is characterised by an increase in VLDL. However, little information...
16.
McNamee P, Trees A, Guy F, Moffett D, Kilpatrick D
Vet Rec
. 1996 Apr;
138(17):419-20.
PMID: 8733183
No abstract available.
17.
18.
Jackson P, Loughrey C, Lightbody J, McNamee P, Young I
Clin Chem
. 1995 Aug;
41(8 Pt 1):1135-8.
PMID: 7628087
Cardiovascular disease is the major cause of mortality in patients receiving hemodialysis for chronic renal failure. Increased lipid peroxidation and depletion of chain-breaking antioxidants may contribute to increased risk of...
19.
Murphy B, Yong A, Brown J, McNamee P
Atherosclerosis
. 1995 Aug;
116(2):241-5.
PMID: 7575779
We have previously studied cardiovascular risk markers apolipoprotein (a) (apo(a)) and plasma fibrinogen in 146 control, 60 haemodialysis (HD), 53 continuous ambulatory peritoneal dialysis (CAPD) and 66 renal transplant subjects....
20.
Loughrey C, Young I, Lightbody J, McMaster D, McNamee P, Trimble E
QJM
. 1994 Nov;
87(11):679-83.
PMID: 7820542
Patients with chronic renal failure, including those receiving regular long-term haemodialysis, have a high incidence of premature cardiovascular disease. Oxidative stress, which occurs when there is excessive free-radical production or...